Ricevi le ultime notizie sulle azioni Insulet con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di PODD

Ultime notizie per

INSULET CORP

Insulet

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Insulet Corp

Press Releases

Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025

Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1)

Insulet to Participate in Upcoming Investor Conferences

Insulet Elevates Eric Benjamin to Chief Operating Officer

Insulet Announces CFO Transition

Insulet and Pantone® Partner to Launch Omnipod® Mango in Vibrant New Palette

Insulet to Host Investor Day on November 20, 2025

Insulet Announces Appointment of Robert L. Huffines to its Board of Directors

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Insulet Reports Third Quarter 2025 Results

PODD

Abbott Laboratories

Baxter Intl

Becton, Dickinson and Company Common Stock

Becton Dickinson

Boston Scientific Corporation Common Stock

Boston Scientific

DexCom

Edwards Lifesciences Corporation Common Stock

Edwards Lifesciences

GE HealthCare Technologies Inc. - Common Stock

GE HealthCare Techs

Glaukos

Globus Medical, Inc. Class A Common Stock

Globus Medical

Hologic

IDEXX Laboratories

iRhythm Technologies, Inc. - Common Stock

iRhythm Technologies

Intuitive Surgical

Masimo

Medtronic

Envista Holdings Corporation Common Stock

Envista Holdings

Penumbra

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips

ResMed

Smith & Nephew

Steris

Stryker

Teleflex

TransMedics Group

Zimmer Biomet Holdings, Inc. Common Stock

Zimmer Biomet Holdings

Jefferies

Barclays

Stifel

Canaccord Genuity

Oppenheimer

Comments

Insulet Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO